RHEOPLEX Canadian Trademark Information

On Tuesday, November 20, 2012, a canadian trademark registration was filed for RHEOPLEX by Intrexon Corporation *********, **********, ***** ****. The Canadian IP office has given the trademark application number of 1603087. The current status of this trademark filing is Interruption of proceeding. The correspondent listed for RHEOPLEX is FASKEN MARTINEAU DUMOULIN LLP of *********, **********, ***** **** The RHEOPLEX trademark is filed in the description of Chemicals, biochemicals and reagents for use in industry and science laboratory research, diagnosis and the treatment of genetic conditions and disorders; chemicals for use in biochemical and chemical industry; chemicals for use in agriculture; chemicals for use in biotechnological product development; chemicals for use in biotechnological manufacturing processes; chemical preparations for scientific purposes, namely, gene therapy, for treating genetic disorders, and for use as medical and veterinary diagnostic reagents for gene therapy analysis; chemical reagents, namely, chemical reagents for use in gene therapy, for treating genetic disorders, and for use as medical and veterinary diagnostic reagents for gene therapy analysis; chemicals, biochemicals and reagents, namely, proteins for regulating, modifying or restricting gene expression, ligands, genetic vectors, genetic hosts, genetic biochemicals, genetic bioengineering reagents and protein receptors for use in regulating cellular functions in transgenic plants, fungi and animals, and in cells of plants, fungi and animals; kits consisting primarily of proteins for regulating, modifying or restricting gene expression; Research reagents for pharmaceutical discovery or disease research, drug discovery or drug development; Chemical inducers of gene expression in plants, mammals, fungi and bacteria for industrial and agricultural applications; Chemical preparations for medical and veterinary purposes, namely, chemical preparations for gene therapy, for treating genetic disorders, and for use as medical and veterinary diagnostic reagents for gene therapy analysis; biochemical preparations for medical and veterinary purposes, namely, biochemical preparations for gene therapy, for treating genetic disorders, and for use as medical and veterinary diagnostic reagents for gene therapy analysis; Chemical inducers of gene expression in plants, mammals, fungi and bacteria for medical and veterinary applications; Chemicals and chemical reagents, namely, cells of transgenic animals, transgenic plants and transgenic fungi, and cells of animals, plants or fungi for use in medical, pharmaceutical and veterinary laboratory research; Pharmaceutical and veterinary preparations which regulate the cellular functions of fungi, plants, bacteria and mammals and transgenic fungi, plants, bacteria and mammals; transgenic fungi and bacteria for medical and veterinary purposes .